Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-196317

See Remarks sold 5,000 shares at an average $70.25 ($351,247)

  • See Remarks acquired 5,000 shares (option exercise)
  • See Remarks acquired 400 shares (grant or award)
  • See Remarks gave up 189 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas See Remarks 2025-09-02 Option exercise 10b5-1 +5,000 $13.56 $67,800 15,066 D: show line 1 in the form
Lyon Joseph Douglas See Remarks 2025-09-02 Sale 10b5-1 −4,895 $70.24 $343,818 10,171 D: show line 2 in the form
Lyon Joseph Douglas See Remarks 2025-09-02 Sale 10b5-1 −105 $70.76 $7,429 10,066 D: show line 3 in the form
Lyon Joseph Douglas See Remarks 2025-09-02 Grant or award 10b5-1 +200 $71.38 $14,276 10,266 D: show line 4 in the form
Lyon Joseph Douglas See Remarks 2025-09-02 Grant or award 10b5-1 +200 10,466 D: show line 5 in the form
Lyon Joseph Douglas See Remarks 2025-09-03 Shares withheld for taxes 10b5-1 −189 $71.38 $13,491 10,277 D: show line 6 in the form
Open-market sales · 5,000 sh · avg $70.25 · $351,247

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lyon Joseph Douglas See Remarks 2025-09-02 Option exercise · Stock option (right to buy) 10b5-1 −5,000 26,571 D: show line 7 in the form
Loading xslF345X05/ownership.xml…